Zia Ullah Shah: Advancing Early Diagnosis of Wilson Disease With AI and Biomarkers
Zia Ullah Shah, Master of Philosophy (MPhil) in Medical Laboratory Sciences at Kohat University of Science and Technology, shared a post on LinkedIn:
“A proud milestone in my research journey
I am delighted to share that my review paper abstract has been selected for poster presentation at the Rare Disease Research Conference 2026, taking place on 5 November 2026 at O’Reilly Hall, University College Dublin, Ireland.
My work focuses on emerging biomarkers and artificial intelligence-assisted approaches for the early laboratory diagnosis of Wilson disease, exploring how advances in laboratory medicine can contribute to improved diagnosis of rare diseases.
Although I will unfortunately be unable to attend the conference in person due to international travel constraints, I am deeply grateful for the opportunity to have my review paper abstract is selected for poster presentation at an international scientific conference.
This recognition motivates me to continue developing my research skills and contributing to medical laboratory sciences, molecular diagnostics, and biomedical research, while working toward my long-term goal of pursuing doctoral research.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian